Rada J A, Achen V R, Perry C A, Fox P W
Department of Anatomy and Cell Biology, University of North Dakota, School of Medicine, Grand Forks 58202, USA.
Invest Ophthalmol Vis Sci. 1997 Aug;38(9):1740-51.
The proteoglycans synthesized and accumulated within the adult human sclera (aged 50 to 80 years) were identified by their size, glycosaminoglycan side chains, and core proteins in an effort to characterize the proteoglycan content of the human sclera.
Sclerae, unlabeled, or radiolabeled in organ culture with 35SO4 or 3H-proline, were extracted in 4M guanidine-HCl and separated by Sepharose CL-2B and Superose 6 forced-pressure liquid chromatography. Peak fractions, identified by glycosaminoglycan content or radioactivity, were pooled and subjected to G-50 chromatography or sodium dodecyl sulfate-polyacrylamide gel electrophoresis before and after digestion with specific glycosidases. Scleral proteoglycan core proteins were identified in Western blot analysis using specific antisera to decorin, biglycan, and aggrecan. Reverse transcription-polymerase chain reaction analyses were carried out on human scleral fibroblast RNA to confirm the transcription of one scleral proteoglycan. Proteoglycans were localized on sections of scleral tissue using specific antisera.
After chromatography on CL-2B, scleral proteoglycans could be resolved into three major peaks, PG-1, PG-2, and PG-3. The largest scleral proteoglycan, PG-1, contained chondroitin sulfate and keratan sulfate glycosaminoglycan side chains. Results of Western blot analyses indicated that the core protein of PG-1 is the aggrecan core protein, migrating at approximately 350 kDa. Reverse transcription-polymerase chain reaction analyses confirmed that human scleral fibroblasts transcribe aggrecan in vitro and in vivo. PG-2 and PG-3 were identified as biglycan and decorin in Western blot analyses using antibiglycan and antidecorin antibodies, respectively. Immunostaining results indicated that aggrecan, biglycan, and decorin are distributed throughout the thickness of the human sclera.
The adult human sclera contains three major proteoglycans; aggrecan, biglycan, and decorin. It is likely that these proteoglycans contribute to the structural properties of the sclera and that the ratios of these proteoglycans will change with age, specific region, and condition of the sclera.
通过其大小、糖胺聚糖侧链和核心蛋白来鉴定在成人巩膜(年龄50至80岁)中合成并积累的蛋白聚糖,以表征人巩膜的蛋白聚糖含量。
将未标记的或在器官培养中用35SO4或3H-脯氨酸进行放射性标记的巩膜,在4M盐酸胍中提取,并通过琼脂糖CL-2B和Superose 6强制压力液相色谱进行分离。通过糖胺聚糖含量或放射性鉴定的峰级分被合并,并在用特定糖苷酶消化之前和之后进行G-50色谱分析或十二烷基硫酸钠-聚丙烯酰胺凝胶电泳。使用针对核心蛋白聚糖、双糖链蛋白聚糖和聚集蛋白聚糖的特异性抗血清,在蛋白质印迹分析中鉴定巩膜蛋白聚糖核心蛋白。对人巩膜成纤维细胞RNA进行逆转录-聚合酶链反应分析,以确认一种巩膜蛋白聚糖的转录。使用特异性抗血清将蛋白聚糖定位在巩膜组织切片上。
在CL-2B上进行色谱分析后,巩膜蛋白聚糖可分为三个主要峰,PG-1、PG-2和PG-3。最大的巩膜蛋白聚糖PG-1含有硫酸软骨素和硫酸角质素糖胺聚糖侧链。蛋白质印迹分析结果表明,PG-1的核心蛋白是聚集蛋白聚糖核心蛋白,迁移率约为350 kDa。逆转录-聚合酶链反应分析证实,人巩膜成纤维细胞在体外和体内转录聚集蛋白聚糖。在蛋白质印迹分析中,分别使用抗双糖链蛋白聚糖抗体和抗核心蛋白聚糖抗体将PG-2和PG-3鉴定为双糖链蛋白聚糖和核心蛋白聚糖。免疫染色结果表明,聚集蛋白聚糖、双糖链蛋白聚糖和核心蛋白聚糖分布于人巩膜的整个厚度。
成人巩膜含有三种主要蛋白聚糖;聚集蛋白聚糖、双糖链蛋白聚糖和核心蛋白聚糖。这些蛋白聚糖可能对巩膜的结构特性有贡献,并且这些蛋白聚糖的比例可能会随着年龄、特定区域和巩膜状况而变化。